MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
$765,890
EPS
$0.01
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-04-30
2026-01-31
2025-10-31
2025-07-31
Research and development expense
-
-
-
0*
General and administrative expense
297,554
181,942
303,190
255,188.25*
Loss from operations
-297,554
-181,942
-303,190
-255,188.25*
Gain on sale of product candidates and related assets
-
-
-
0*
Impairment of investment in preferred stock of oragenics, inc
-
-
-
0*
Loss from change in fair value of oragenics, inc. common stock
0
0
0
-114,854.25*
Interest expense
527,551
412,429
95,336
63,129*
Financing costs
0
2,572,655
507,368
-
Change in fair value of derivative liability
1,505,581
-424,348
422,419
-
Gain on extinguishment of accounts payable
85,369
-
-
-
Other income (expense), net
45
-10,249
28
-2,501.25*
Net income (loss) and comprehensive income (loss)
765,890
-3,601,623
-483,447
-435,672.75*
Deemed dividend
-
-
-
0*
Net loss attributable to common stockholders
-
-
-
-435,672.75
Basic EPS
0.01
-0.03
0
-0.004
Diluted EPS
0.01
-0.03
0
-0.004
Basic Average Shares
108,031,419
107,853,763
106,036,632
104,709,763
Diluted Average Shares
186,674,907
107,853,763
106,036,632
104,709,763
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Change in fair value of
derivative liability
$1,505,581
Gain on
extinguishment of accounts...
$85,369
Other income
(expense), net
$45
Net income (loss)
and comprehensive...
$765,890
Interest expense
$527,551
Loss from operations
-$297,554
General and
administrative expense
$297,554
Buy us a coffee
Odyssey Health, Inc. (ODYY)
Odyssey Health, Inc. (ODYY)